4 minutes
Glasgow-based Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of pharma, has closed a £1.5 million funding round to support its ambitions for expansion into the US. Boston based life science investor Mark Ba
3 minutes
Glasgow-based Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, has secured a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment. Tern Plc, the investment company specialising in
SUBSCRIBE
